Yong Ling

4.5k total citations · 1 hit paper
167 papers, 3.5k citations indexed

About

Yong Ling is a scholar working on Molecular Biology, Organic Chemistry and Biomedical Engineering. According to data from OpenAlex, Yong Ling has authored 167 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Molecular Biology, 49 papers in Organic Chemistry and 31 papers in Biomedical Engineering. Recurrent topics in Yong Ling's work include Nanoplatforms for cancer theranostics (28 papers), Synthesis and biological activity (16 papers) and Histone Deacetylase Inhibitors Research (12 papers). Yong Ling is often cited by papers focused on Nanoplatforms for cancer theranostics (28 papers), Synthesis and biological activity (16 papers) and Histone Deacetylase Inhibitors Research (12 papers). Yong Ling collaborates with scholars based in China, Taiwan and United States. Yong Ling's co-authors include Yanan Zhang, Gong‐Qing Liu, Dong Liang, Yanfei Liu, Yan Wang, Zhi‐You Hao, Chun‐Lei Zhang, Chi Meng, Jianqiang Qian and Huimin Wang and has published in prestigious journals such as Analytical Chemistry, Journal of The Electrochemical Society and Bioresource Technology.

In The Last Decade

Yong Ling

160 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design

2021 250 citations Yong Ling et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yong Ling China	33	1.3k	1.2k	366	335	275	167	3.5k
Christina L. L. Chai Singapore	37	1.5k 1.2×	2.5k 2.1×	229 0.6×	292 0.9×	225 0.8×	178	4.5k
Rita Lang Austria	5	1.8k 1.5×	929 0.8×	283 0.8×	212 0.6×	189 0.7×	7	4.5k
Jari Yli‐Kauhaluoma Finland	37	2.3k 1.8×	1.2k 1.0×	697 1.9×	251 0.7×	174 0.6×	202	5.0k
Obaid Afzal Saudi Arabia	37	1.7k 1.3×	1.1k 0.9×	443 1.2×	291 0.9×	78 0.3×	187	4.4k
Mohamed A. Abdelgawad Saudi Arabia	34	1.1k 0.8×	1.8k 1.5×	328 0.9×	220 0.7×	147 0.5×	217	4.2k
Amita Verma India	35	964 0.8×	947 0.8×	179 0.5×	445 1.3×	95 0.3×	222	4.2k
Yeon‐Ju Lee South Korea	33	1.5k 1.2×	1.2k 1.0×	389 1.1×	208 0.6×	85 0.3×	215	3.8k
Paolo Paoli Italy	34	2.2k 1.7×	565 0.5×	298 0.8×	222 0.7×	186 0.7×	116	4.2k
Siavoush Dastmalchi Iran	31	1.3k 1.0×	610 0.5×	302 0.8×	321 1.0×	65 0.2×	178	3.2k
Chin‐Chung Wu Taiwan	42	2.5k 1.9×	955 0.8×	283 0.8×	414 1.2×	210 0.8×	191	6.3k

Countries citing papers authored by Yong Ling

Since Specialization

Citations

This map shows the geographic impact of Yong Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Ling more than expected).

Fields of papers citing papers by Yong Ling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Ling. The network helps show where Yong Ling may publish in the future.

Co-authorship network of co-authors of Yong Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Ling. A scholar is included among the top collaborators of Yong Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Ling. Yong Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sun, Tiantian, Sijia Wang, Xiao Liu, et al.. (2025). Novel ꞵ-carboline/cyanoisoflavone photosensitizers for ferroptosis-induced efficient chemo-photodynamic synergistic cancer therapy. Journal of Photochemistry and Photobiology B Biology. 265. 113135–113135. 1 indexed citations

Chen, Jian‐Min, Yangyang Jiang, Ke Xu, et al.. (2025). Novel one−/two-photon excited β-carboline/quinolinium photosensitizers for hypoxia-resistant tumor photodynamic therapy through apoptosis and necrosis. Bioorganic Chemistry. 161. 108538–108538.

Sun, Tiantian, Kai Wang, Zirui Zhang, et al.. (2025). Novel one-/two-photon excited carbazole/quinolinium photosensitizers manifest nanomolar and hypoxia-resistant tumor photodynamic therapy by accelerating apoptosis, ferroptosis, and autophagy. European Journal of Medicinal Chemistry. 290. 117523–117523. 2 indexed citations

Zheng, Hongwei, Hongmei Wu, Dezhi Wang, et al.. (2024). Research progress of prodrugs for the treatment of cerebral ischemia. European Journal of Medicinal Chemistry. 272. 116457–116457. 4 indexed citations

Liu, Mingxuan, Yuting Cai, Pengfei Zhu, et al.. (2024). Aggregation-Induced Emission CN-Based Nanoparticles to Alleviate Hypoxic Liver Fibrosis via Triggering HSC Ferroptosis and Enhancing Photodynamic Therapy. ACS Applied Materials & Interfaces. 16(26). 33021–33037. 12 indexed citations

Gui, Lijuan, Weiqing Li, Yanping Pan, et al.. (2023). γ-Glutamyl transpeptidase activatable probe for fluorescence-assisted guiding surgery and imaging of human tumors via spraying. Sensors and Actuators B Chemical. 398. 134718–134718. 5 indexed citations

Xu, Zhongyuan, Jianqiang Qian, Hongmei Wu, et al.. (2023). Novel pH-activatable NIR fluorogenic spray mediated near-instant and precise tumor margins identification in human cancer tissues for surgical resection. Theranostics. 13(13). 4497–4511. 5 indexed citations

Chen, Bei, Jianbing Wu, Hongmei Wu, et al.. (2023). 1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis. Journal of Medicinal Chemistry. 66(24). 16680–16693. 7 indexed citations

Wang, Haoran, Shanshan Huang, Biao Xiong, et al.. (2023). Photoredox catalysis in alkene and alkyne alkylsulfonylations: the construction of Markovnikov selective α-sulfones. Chemical Communications. 59(69). 10420–10423. 7 indexed citations

10.

Xu, Zhongyuan, Jianqiang Qian, Huimin Zhao, et al.. (2023). Dual Tumor-Selective β-Carboline-Based Fluorescent Probe for High-Contrast/Rapid Diagnosis of Clinical Tumor Tissues. Molecular Pharmaceutics. 21(1). 152–163. 4 indexed citations

11.

Wang, Pengfei, Wei Yi, Yong Ling, et al.. (2021). Preparation of selenofunctionalized heterocycles via iodosobenzene-mediated intramolecular selenocyclizations of olefins with diselenides. Chinese Chemical Letters. 32(8). 2587–2591. 28 indexed citations

12.

Liu, Xin, Chi Meng, Ji Liu, et al.. (2021). Tumor microenvironment-activatable boolean logic supramolecular nanotheranostics based on a pillar[6]arene for tumor hypoxia imaging and multimodal synergistic therapy. Materials Chemistry Frontiers. 5(15). 5846–5856. 10 indexed citations

13.

Liu, Gong‐Qing, Yun‐Qian Zhang, Wei Yi, et al.. (2021). Visible-light-induced intermolecular aminoselenation of alkenes. Green Chemistry. 23(24). 9968–9973. 31 indexed citations

14.

Zhu, Peng, Jianqiang Qian, Zhongyuan Xu, et al.. (2020). Piperlonguminine and Piperine Analogues as TrxR Inhibitors that Promote ROS and Autophagy and Regulate p38 and Akt/mTOR Signaling. Journal of Natural Products. 83(10). 3041–3049. 31 indexed citations

15.

Wu, Jianbing, Chenxi Yang, Tian Lv, et al.. (2020). Tetrazine-mediated bioorthogonal removal of 3-isocyanopropyl groups enables the controlled release of nitric oxide in vivo. Biomaterials Science. 9(5). 1816–1825. 9 indexed citations

16.

Liu, Ji, Xin Liu, Jianqiang Qian, et al.. (2020). Development of pH/Glutathione-Responsive Theranostic Agents Activated by Glutathione S-Transferase π for Human Colon Cancer. Journal of Medicinal Chemistry. 63(17). 9271–9283. 25 indexed citations

17.

Chen, Zhong, Kuo‐Yen Huang, Yong Ling, et al.. (2019). Discovery of an Oleanolic Acid/Hederagenin–Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer. Journal of Natural Products. 82(11). 3065–3073. 41 indexed citations

18.

Dai, Hong, Meiling Huang, Jianqiang Qian, et al.. (2019). Excellent antitumor and antimetastatic activities based on novel coumarin/pyrazole oxime hybrids. European Journal of Medicinal Chemistry. 166. 470–479. 51 indexed citations

19.

Ling, Yong, Yu‐Ning Teng, Shi Chen, et al.. (2018). Development of novel amino-quinoline-5,8-dione derivatives as NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibitors with potent antiproliferative activities. European Journal of Medicinal Chemistry. 154. 199–209. 31 indexed citations

20.

Dai, Hong, Shushan Ge, Jing Guo, et al.. (2017). Development of novel bis-pyrazole derivatives as antitumor agents with potent apoptosis induction effects and DNA damage. European Journal of Medicinal Chemistry. 143. 1066–1076. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact